Charles Schwab Investment Management Inc. Boosts Stock Holdings in The Chemours Company (NYSE:CC)

Charles Schwab Investment Management Inc. grew its stake in shares of The Chemours Company (NYSE:CC) by 6.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,302,272 shares of the specialty chemicals company’s stock after acquiring an additional 73,220 shares during the period. Charles Schwab Investment Management Inc. owned 0.87% of Chemours worth $22,008,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in CC. Victory Capital Management Inc. lifted its position in shares of Chemours by 206.2% during the third quarter. Victory Capital Management Inc. now owns 103,259 shares of the specialty chemicals company’s stock worth $2,098,000 after acquiring an additional 69,531 shares in the last quarter. Oppenheimer & Co. Inc. purchased a new stake in shares of Chemours during the third quarter worth $285,000. KBC Group NV lifted its position in shares of Chemours by 19.5% during the third quarter. KBC Group NV now owns 4,468 shares of the specialty chemicals company’s stock worth $91,000 after acquiring an additional 728 shares in the last quarter. Quest Partners LLC lifted its position in shares of Chemours by 7,206.4% during the third quarter. Quest Partners LLC now owns 7,964 shares of the specialty chemicals company’s stock worth $162,000 after acquiring an additional 7,855 shares in the last quarter. Finally, Prospera Private Wealth LLC purchased a new stake in shares of Chemours in the third quarter worth $75,000. Hedge funds and other institutional investors own 76.26% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on CC shares. Truist Financial started coverage on Chemours in a research report on Tuesday, January 28th. They issued a “buy” rating and a $27.00 price objective on the stock. Morgan Stanley lowered their price objective on Chemours from $25.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Monday, January 13th. The Goldman Sachs Group lowered their price objective on Chemours from $24.00 to $21.00 and set a “neutral” rating on the stock in a research report on Tuesday, January 7th. BMO Capital Markets lowered their price objective on Chemours from $34.00 to $27.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 19th. Finally, Mizuho lowered their price objective on Chemours from $22.00 to $21.00 and set a “neutral” rating on the stock in a research report on Tuesday, January 7th. Five research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $23.11.

Chemours Stock Up 0.2 %

CC opened at $14.63 on Wednesday. The stock has a market cap of $2.19 billion, a PE ratio of 25.66 and a beta of 2.00. The company has a quick ratio of 0.92, a current ratio of 1.68 and a debt-to-equity ratio of 6.70. The Chemours Company has a 52 week low of $13.09 and a 52 week high of $29.21. The business’s fifty day simple moving average is $17.08 and its 200 day simple moving average is $18.42.

Chemours (NYSE:CC) last released its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of $0.10 by $0.01. The business had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.37 billion. Chemours had a return on equity of 26.54% and a net margin of 1.51%. As a group, research analysts expect that The Chemours Company will post 2.03 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were paid a dividend of $0.25 per share. The ex-dividend date was Friday, February 28th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 6.84%. Chemours’s dividend payout ratio (DPR) is currently 175.44%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.